Results 21 to 30 of about 2,107,233 (243)

Transcatheter intervention in a child with scimitar syndrome [PDF]

Cardiovascular Journal of Africa, 2016
Scimitar syndrome is a rare congenital heart disease characterised by anomalous pulmonary venous drainage to the inferior vena cava, aortopulmonary collaterals, hypoplasia of the right lung and intracardiac defects. Surgical correction remains the gold-standard therapy.
Wang, Zhouping, Cai, Xiaoyi
openaire   +2 more sources

Transcatheter interventions for functional mitral regurgitation [PDF]

Annals of Cardiothoracic Surgery, 2018
Mitral regurgitation is considered the most prevalent valve disease in the United States and its incidence is increasing due to the aging population. Surgical mitral valve repair and replacement are effective at reducing regurgitation due to ischemia, but many patients with secondary mitral regurgitation do not undergo surgery because they are too high
William Z, Chancellor, Sarah A, Schubert, Gorav, Ailawadi   +2 more
openaire   +2 more sources

Transcatheter Tricuspid Valve Interventions: A Triumph for Transcatheter Procedures?

Life, 2023
Tricuspid regurgitation (TR) is a common valvular pathology, estimated to affect 1.6 million people in the United States alone. Even though guidelines recommend either medical therapy or surgical treatment for TR, the misconception of TR as a benign disease along with the high mortality rates of surgical intervention led to undertreating this disease ...
Kyriakos Dimitriadis, Nikolaos Pyrpyris, Konstantinos Aznaouridis, Panagiotis Iliakis, Aggeliki Valatsou, Panagiotis Tsioufis, Eirini Beneki, Emmanouil Mantzouranis, Konstantina Aggeli, Eleftherios Tsiamis, Konstantinos Tsioufis   +10 more
openaire   +4 more sources

Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)- systematic review and meta-analysis [PDF]

, 2014
The hypothesis of this study was that local anesthesia with monitored anesthesia care (MAC) is not harmful in comparison to general anesthesia (GA) for patients undergoing Transcatheter Aortic Valve Implantation (TAVR).TAVR is a rapidly spreading ...
Webb, J, Reinthaler, M, Georg M Fröhlich, Marco Roffi, Olaf Wendler, Nevil Hutchinson, Markus Reinthaler, Duolao Wang, David Hildick-Smith, Wang, D, Hutchinson, N, Fröhlich, GM, John Webb, Pascal Meier, Alexandra J Lansky, Wendler, O, Hildick-Smith, D, Stefan Toggweiler, Lansky, AJ, Roffi, M, Meier, P, Toggweiler, S, Roffi, Marco, Wendler, Olaf, Webb, John, Lansky, Alexandra J, Wang, Duolao, Meier, Pascal, Hildick-Smith, David, Hutchinson, Nevil, Toggweiler, Stefan, Fröhlich, Georg M, Reinthaler, Markus   +32 more
core   +2 more sources

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias, Schoenermarck, Ulf, Rau, Simon, Fischereder, Michael, Steinbeck, Gerhard, Kupatt, Christian, Lange, Philipp   +6 more
core   +1 more source

Operative management after transcatheter aortic valve replacement [PDF]

, 2023
With broadening applications of transcatheter aortic valve replacement (TAVR) and increasing use in intermediate- and low-risk patients, the incidence of surgical re-interventions after TAVR is growing. Transcatheter heart valves suffer from similar long-
Crestanello, Juan A; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, United States, Arghami, Arman; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, United States, Marin-Cuartas, Mateo; University Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany, Noack, Thilo; University Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany, Borger, Michael A; University Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany, Mazur, Piotr; University Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, United States, Michael A Borger, Mateo Marin-Cuartas, Thilo Noack, Juan A Crestanello, Piotr Mazur, Arman Arghami   +11 more
core   +1 more source

Utility of MitraClip XTR system in percutaneous edge-to-edge mitral valve repair for severe flail leaflet

Heart Views, 2020
Transcatheter mitral valve (MV) edge-to-edge repair provided alternative solutions to high surgical risk patients with degenerative MV regurgitation (MR) and patients with functional MR leading to symptomatic heart failure.
Mohammed Al-Hijji, Abdallah El Sabbagh, Erin A Fender, Jeremy Thaden, Charanjit S Rihal, Mackram F Eleid   +5 more
doaj   +1 more source

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]

, 2012
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R, Dewey, Todd M, Pocock, Stuart, Brown, David L, Pichard, Augusto D, Bowers, Bruce, Siegel, Robert J, Smith, Craig R, Webb, John G, Tuzcu, Murat, Moses, Jeffrey W, Williams, Matthew R, Babaliaros, Vasilis C, Thourani, Vinod H, Kapadia, Samir, Svensson, Lars G, Jilaihawi, Hasan, Kodali, Susheel, Bavaria, Joseph E, MD, Fontana, Gregory P, Akin, Jodi J, Douglas, Pamela S, Bavaria, Joseph E, Herrmann, Howard C, Leon, Martin B, PARTNER Trial Investigators, Anderson, William N   +26 more
core   +1 more source

Long-term Transcatheter Aortic Valve Durability [PDF]

, 2019
Transcatheter aortic valve implantation (TAVI) has become the standard of care for high-risk and inoperable surgical patients and a valid alternative to surgery for low- and intermediate-risk patients with severe, symptomatic aortic stenosis.
Enrico Criscione, Denise Todaro, Marco Barbanti, Corrado Tamburino, Giuliano Costa   +4 more
core   +1 more source

Prognostic Impact of Pre‐Transcatheter and Post‐Transcatheter Aortic Valve Intervention Troponin: A Large Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Biomarkers were advocated as prognostic factors in patients undergoing transcatheter aortic valve intervention, with contradictory results concerning prognostic impact of troponin.
Mariama Akodad, Marco Spaziano, Bernard Chevalier, Philippe Garot, Hakim Benamer, Annabelle Dinan‐Zannier, Xavier Troussier, Thierry Unterseeh, Stéphane Champagne, Thomas Hovasse, Thierry Lefèvre   +10 more
doaj   +1 more source